Tropoflex
Overview
1. Inflammation induces a cascade of enzymic activity that degrades collagen structure and tissue integrity. TropoFlex inhibits this inflammatory cascade and blocks the degradation of collagen, enabling regeneration to occur.
Funding and backers
Total raised
$250k
1 round on record
Latest round
$250k
Venture round · Sep 2025 · 13 mo ago
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2025 | $250k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Tropoflex Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Paul CastellaExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

GeniPhys is developing and commercializing its patented Collymer ™ technology -a first-in-class polymerizable (scaffold-forming) collagen…

HyFaCol is a Collagen Manufacturing Platform which significantly improves the production and quality of medical grade collagen.

The All-In-One Multi Collagen blend, made locally in the UK, containing clinically effective doses of marine collagen and bovine collagen…

Collagen-based innovation that addresses complex tissue engineering and regenerative medical needs, helping to shape next-generation…

Command your entire payment stack from one platform. Corefy connects 650+ providers, routes and cascades transactions, and lifts approval…

TRIANA Biomedicines discovers and develops molecular glue therapeutics employing a target first and rational molecular glue discovery…
Financials
Total raised
$250k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $250k | Details |
People

Paul Castella
Executive Officer, Director

Bryan Daniels
Director

Kristen Parker
Director

Kevin Meehan
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Antonio
United States
HQ






